Almendros, IsaacMartínez-García, Miguel ÁngelCampos-Rodríguez, FranciscoRiveiro-Falkenbach, EricaRodríguez-Peralto, José LNagore, EduardoMartorell-Calatayud, AntonioHernández Blasco, LuisBañuls Roca, JoseChiner Vives, EusebiSánchez-de-la-Torre, AliciaAbad-Capa, JorgeMontserrat, Josep MariaPérez-Gil, AmaliaCabriada-Nuño, ValentínCano-Pumarega, IreneCorral-Peñafiel, JaimeDiaz-Cambriles, TrinidadMediano, OlgaDalmau-Arias, JoanFarré, RamonGozal, DavidSpanish Sleep Network2023-01-252023-01-252018-04-261664-2295http://hdl.handle.net/10668/12458Epidemiological associations linking between obstructive sleep apnea and poorer solid malignant tumor outcomes have recently emerged. Putative pathways proposed to explain that these associations have included enhanced hypoxia inducible factor (HIF)-1α and vascular endothelial growth factor (VEGF) cell expression in the tumor and altered immune functions via intermittent hypoxia (IH). Here, we examined relationships between HIF-1α and VEGF expression and nocturnal IH in cutaneous melanoma (CM) tumor samples. Prospectively recruited patients with CM tumor samples were included and underwent overnight polygraphy. General clinical features, apnea-hypopnea index (AHI), desaturation index (DI4%), and CM characteristics were recorded. Histochemical assessments of VEGF and HIF-1α were performed, and the percentage of positive cells (0, 75%) was blindly tabulated for VEGF expression, and as 0, 0-5.9, 6.0-10.0, >10.0% for HIF-1α expression, respectively. Cases with HIF-1α expression >6% (high expression) were compared with those 10.0% for HIF-1α expression, respectively. Cases with HIF-1α expression >6% (high expression) were compared with those 6% (high expression) were compared with those 75% of cells was compared with those withenAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/hypoxia-inducible factorintermittent hypoxiamelanomaobstructive sleep apneavascular endothelial growth factorIntermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients.research article29755400open access10.3389/fneur.2018.00272PMC5932170https://www.frontiersin.org/articles/10.3389/fneur.2018.00272/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932170/pdf